周元華醫師

學歷:

瑞典卡洛林斯卡醫學大學博士

加拿大多倫多大學研究員

新加坡管理大學碩士

國防醫學院藥理學碩士

國防醫學院醫學士

專長:

疼痛、失眠、情緒障礙

現職:

臺中榮民總醫院精神部 部主任

經歷:

臺北榮民總醫院品質管理中心主任

三軍總醫院精神科主任

臺北榮民總醫院精神科主任

量表

論文發表:

1991-1995

  1. Chou, Y.H., J. Wei, and C.I. Lin, Halothane inhibits residual fast sodium channels in human atrial muscle. Anesthesiology, 1991. 75(4): p. 716-7.

1996-2000

  1. Halldin, C., C. Foged, Y.H. Chou, P. Karlsson, C.G. Swahn, J. Sandell, G. Sedvall, and L. Farde, Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors. J Nucl Med, 1998. 39(12): p. 2061-8.
  2. Gulyas, B., C. Halldin, P. Karlsson, Y.H. Chou, C.G. Swahn, P. Bonock, M. Paroczai, and L. Farde, Brain uptake and plasma metabolism of [11C]vinpocetine: a preliminary PET study in a cynomolgus monkey. J Neuroimaging, 1999. 9(4): p. 217-22.
  3. Chou, Y.H., P. Karlsson, C. Halldin, H. Olsson, and L. Farde, A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain. Psychopharmacology (Berl), 1999. 146(2): p. 220-7.
  4. Helfenbein, J., J. Sandell, C. Halldin, S. Chalon, P. Emond, Y. Okubo, Y.H. Chou, Y. Frangin, L. Douziech, L. Gareau, C.G. Swahn, J.C. Besnard, L. Farde, and D. Guilloteau, PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter. Nucl Med Biol, 1999. 26(5): p. 491-9.
  5. Gulyas, B., C. Halldin, P. Karlsson, Y.H. Chou, C.G. Swahn, P. Bonoczk, and L. Farde, [Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies]. Orv Hetil, 1999. 140(30): p. 1687-91.
  6. Farde, L., N. Ginovart, C. Halldin, Y.H. Chou, H. Olsson, and C.G. Swahn, A PET study of. Int J Neuropsychopharmacol, 2000. 3(3): p. 203-214.
  7. Chou, Y.H., C. Halldin, and L. Farde, Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study. Synapse, 2000. 38(2): p. 138-43.

2001-2005

  1. Sandell, J., C. Halldin, V.W. Pike, Y.H. Chou, K. Varnas, H. Hall, S. Marchais, B. Nowicki, H.V. Wikstrom, C.G. Swahn, and L. Farde, New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY–radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey. Nucl Med Biol, 2001. 28(2): p. 177-85.
  2. Sandell, J., C. Halldin, J. Sovago, Y.H. Chou, B. Gulyas, M. Yu, P. Emond, K. Nagren, D. Guilloteau, and L. Farde, PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter. Nucl Med Biol, 2002. 29(6): p. 651-6.
  3. Nyberg, S., Y.H. Chou, and C. Halldin, Saturation of striatal D(2) dopamine receptors by clozapine. Int J Neuropsychopharmacol, 2002. 5(1): p. 11-6.
  4. Sandell, J., C. Halldin, Y.H. Chou, C.G. Swahn, S.O. Thorberg, and L. Farde, PET-examination and metabolite evaluation in monkey of [(11)C]NAD-299, a radioligand for visualisation of the 5-HT(1A) receptor. Nucl Med Biol, 2002. 29(1): p. 39-45.
  5. Halldin, C., N. Erixon-Lindroth, S. Pauli, Y.H. Chou, Y. Okubo, P. Karlsson, C. Lundkvist, H. Olsson, D. Guilloteau, P. Emond, and L. Farde, [(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain. Eur J Nucl Med Mol Imaging, 2003. 30(9): p. 1220-30.
  6. Chou, Y.H., C. Halldin, and L. Farde, Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study. Psychopharmacology (Berl), 2003. 166(3): p. 234-40.
  7. Huang, W.S., Y.H. Chiang, J.C. Lin, Y.H. Chou, C.Y. Cheng, and R.S. Liu, Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson’s disease patients. J Nucl Med, 2003. 44(7): p. 999-1005.
  8. Huang, W.S., K.H. Ma, Y.H. Chou, C.Y. Chen, R.S. Liu, and J.C. Liu, 99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET. Nucl Med Commun, 2003. 24(1): p. 77-83.
  9. Huang, W.S., K.H. Ma, C.Y. Cheng, C.Y. Chen, Y.K. Fu, Y.H. Chou, S.P. Wey, and J.C. Liu, Imaging serotonin transporters with 123I-ADAM brain SPECT in healthy non-human primates. Nucl Med Commun, 2004. 25(5): p. 515-9.
  10. Huang, S.Y., W.W. Lin, H.C. Ko, J.F. Lee, T.J. Wang, Y.H. Chou, S.J. Yin, and R.B. Lu, Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res, 2004. 28(3): p. 374-84.
  11. Chen, C.K. and Y.H. Chou, Amisulpride-associated pedal edema. Eur Psychiatry, 2004. 19(7): p. 454-5.
  12. Marchais-Oberwinkler, S., B. Nowicki, V.W. Pike, C. Halldin, J. Sandell, Y.H. Chou, B. Gulyas, L.T. Brennum, L. Farde, and H.V. Wikstrom, N-oxide analogs of WAY-100635: new high affinity 5-HT(1A) receptor antagonists. Bioorg Med Chem, 2005. 13(3): p. 883-93.
  13. Lu, R.B., H.C. Ko, J.F. Lee, W.W. Lin, S.Y. Huang, T.J. Wang, Y.S. Wu, T.E. Lu, and Y.H. Chou, No alcoholism-protection effects of ADH1B*2 allele in antisocial alcoholics among Han Chinese in Taiwan. Alcohol Clin Exp Res, 2005. 29(12): p. 2101-7.
  14. Yang, Y.K., Y.H. Tarn, T.Y. Wang, C.Y. Liu, Y.C. Laio, Y.H. Chou, S.M. Lee, and C.C. Chen, Pharmacoeconomic evaluation of schizophrenia in Taiwan: model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs. Psychiatry Clin Neurosci, 2005. 59(4): p. 385-94.

2006-2010

  1. Chou, Y.H., C. Halldin, and L. Farde, Clozapine binds preferentially to cortical D1-like dopamine receptors in the primate brain: a PET study. Psychopharmacology (Berl), 2006. 185(1): p. 29-35.
  2. Yeh, C.B., C.H. Lee, Y.H. Chou, C.J. Chang, K.H. Ma, and W.S. Huang, Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette’s adults. Nucl Med Commun, 2006. 27(10): p. 779-84.
  3. Ku, H.L., T.P. Su, and Y.H. Chou, Ziprasidone-associated pedal edema in the treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 2006. 30(5): p. 963-4.
  4. Wang, T.S., Y.H. Chou, and I.S. Shiah, Combined treatment of olanzapine and mirtazapine in anorexia nervosa associated with major depression. Prog Neuropsychopharmacol Biol Psychiatry, 2006. 30(2): p. 306-9.
  5. Chou, Y.H., W.S. Huang, T.P. Su, R.B. Lu, F.J. Wan, and Y.K. Fu, Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study. Eur Neuropsychopharmacol, 2007. 17(1): p. 46-52.
  6. Lee, S.M., Y.H. Chou, M.H. Li, F.J. Wan, and M.H. Yen, Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry, 2007. 31(5): p. 1101-7.
  7. Liao, Y.L., Y.N. Sun, W.Y. Guo, Y.H. Chou, J.C. Hsieh, and Y.T. Wu, A comparison between the surface-based and mutual-information-based methods for co-registering SPECT and MR images. Conf Proc IEEE Eng Med Biol Soc, 2007. 2007: p. 868-71.
  8. Yang, B.H., S.J. Wang, Y.H. Chou, T.P. Su, S.P. Chen, J.S. Lee, and J.C. Chen, Evaluation of reference tissue model and tissue ratio method for 5-HTT using [(123)I] ADAM tracer. Comput Methods Programs Biomed, 2008. 92(3): p. 294-8.
  9. Lee, S.M., Y.H. Chou, M.H. Li, F.J. Wan, and M.H. Yen, Effects of haloperidol and risperidone on cerebrohemodynamics in drug-naive schizophrenic patients. J Psychiatr Res, 2008. 42(4): p. 328-35.
  10. Huang, C.C., I.H. Wei, Y.H. Chou, and T.P. Su, Effect of age, gender, menopausal status, and ovarian hormonal level on rTMS in treatment-resistant depression. Psychoneuroendocrinology, 2008. 33(6): p. 821-31.
  11. Yang, K.C., T.P. Su, and Y.H. Chou, Effectiveness of aripiprazole in treating obsessive compulsive symptoms. Prog Neuropsychopharmacol Biol Psychiatry, 2008. 32(2): p. 585-6.
  12. Lin, W.C. and Y.H. Chou, Aripiprazole effects on psychosis and chorea in a patient with Huntington’s disease. Am J Psychiatry, 2008. 165(9): p. 1207-8.
  13. Lin, Y.R., M.H. Wu, C.I. Yang, T.H. Chen, C.C. Hsu, Y.C. Chang, W.C. Tzeng, Y.H. Chou, and K.R. Chou, Evaluation of assertiveness training for psychiatric patients. J Clin Nurs, 2008. 17(21): p. 2875-83.
  14. Yao, W.J., H.A. Pan, Y.K. Yang, Y.H. Chou, S.T. Wang, C.Y. Yu, and H.D. Lin, Reduced frontal perfusion in depressed postmenopausal women: a SPECT study with WCST. Maturitas, 2008. 59(1): p. 83-90.
  15. Chou, Y.H., B.H. Yang, M.Y. Chung, S.P. Chen, T.P. Su, C.C. Chen, and S.J. Wang, Imaging the serotonin transporter using (123)I-ADAM in the human brain. Psychiatry Res, 2009. 172(1): p. 38-43.
  16. Yeh, H.W., N.S. Tzeng, H. Chu, Y.H. Chou, R.B. Lu, A.P. O’Brien, Y.C. Chang, C.J. Hsieh, and K.R. Chou, The risk of eating disorders among female undergraduates in Taiwan. Arch Psychiatr Nurs, 2009. 23(6): p. 430-40.
  17. Chen, W.C., H. Chu, R.B. Lu, Y.H. Chou, C.H. Chen, Y.C. Chang, A.P. O’Brien, and K.R. Chou, Efficacy of progressive muscle relaxation training in reducing anxiety in patients with acute schizophrenia. J Clin Nurs, 2009. 18(15): p. 2187-96.
  18. Li, C.T., Y.H. Chou, and T.P. Su, Duloxetine in treating medically unexplained pain and Raynaud’s phenomenon. J Neuropsychiatry Clin Neurosci, 2009. 21(4): p. 475-6.
  19. Huang, K.L., T.P. Su, T.J. Chen, Y.H. Chou, and Y.M. Bai, Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study. Psychiatry Clin Neurosci, 2009. 63(3): p. 401-9.
  20. Li, C.T., Y.H. Chou, K.C. Yang, C.H. Yang, Y.C. Lee, and T.P. Su, Medically unexplained symptoms and somatoform disorders: diagnostic challenges to psychiatrists. J Chin Med Assoc, 2009. 72(5): p. 251-6.
  21. Su, T.P., L. Zhang, M.Y. Chung, Y.S. Chen, Y.M. Bi, Y.H. Chou, J.L. Barker, J.E. Barrett, D. Maric, X.X. Li, H. Li, M.J. Webster, D. Benedek, J.R. Carlton, and R. Ursano, Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders. J Psychiatr Res, 2009. 43(13): p. 1078-85.
  22. Bai, Y.M., K.H. Chou, C.P. Lin, I.Y. Chen, C.T. Li, K.C. Yang, Y.H. Chou, and T.P. Su, White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study. Schizophr Res, 2009. 109(1-3): p. 167-81.
  23. Yao, W.J., H.A. Pan, S.T. Wang, Y.K. Yang, Y.H. Chou, and H.D. Lin, Frontal cerebral blood flow changes after hormone replacement therapy in depressed postmenopausal women. J Cereb Blood Flow Metab, 2009. 29(12): p. 1885-90.
  24. Chou, Y.H., S.J. Wang, C.L. Lin, W.C. Mao, S.M. Lee, and M.H. Liao, Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study. Bipolar Disord, 2010. 12(3): p. 312-8.
  25. Li, C.T., T.P. Su, Y.H. Chou, Y.C. Lee, M.E. Liu, H.L. Ku, I.K. Shan, and Y.M. Bai, Symptomatic resolution among Chinese patients with schizophrenia and associated factors. J Formos Med Assoc, 2010. 109(5): p. 378-88.
  26. Cheng, K.J., Y.H. Chou, and Y.J. Liou, Efficacy of bupropion for irritable bowel syndrome. Psychosomatics, 2010. 51(6): p. 536-7.
  27. Hu, L.Y. and Y.H. Chou, Manic episode precedes development of early dementia: a case report. Int Psychogeriatr, 2010. 22(5): p. 834-6.
  28. Ku, H.L., K.C. Yang, Y.C. Lee, M.B. Lee, and Y.H. Chou, Predictors of carbon monoxide poisoning-induced delayed neuropsychological sequelae. Gen Hosp Psychiatry, 2010. 32(3): p. 310-4.

2011-2015

  1. Hsu, J.W., S.J. Wang, C.L. Lin, W.C. Hsieh, J.F. Lirng, Y.C. Shen, M.H. Liao, and Y.H. Chou, Short term vs. long term test-retest reproducibility of (1)(2)(3)I-ADAM for the binding of serotonin transporters in the human brain. Psychiatry Res, 2011. 194(3): p. 224-229.
  2. Yang, K.C., H.L. Ku, C.L. Wu, S.J. Wang, C.C. Yang, J.F. Deng, M.B. Lee, and Y.H. Chou, Striatal dopamine transporter binding for predicting the development of delayed neuropsychological sequelae in suicide attempters by carbon monoxide poisoning: A SPECT study. Psychiatry Res, 2011. 194(3): p. 219-223.
  3. Wu, C.L., K.C. Yang, S.J. Wang, and Y.H. Chou, Aripiprazole can treat psychotic features but not motor symptoms of Parkinson’s disease: evidence from a SPECT study. Prog Neuropsychopharmacol Biol Psychiatry, 2011. 35(1): p. 278-9.
  4. Hsu, J.W., T.P. Su, C.Y. Huang, Y.S. Chen, and Y.H. Chou, Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naive first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study. J Clin Psychopharmacol, 2011. 31(5): p. 577-81.
  5. Zhang, L., T.P. Su, K. Choi, W. Maree, C.T. Li, M.Y. Chung, Y.S. Chen, Y.M. Bai, Y.H. Chou, J.L. Barker, J.E. Barrett, X.X. Li, H. Li, D.M. Benedek, and R. Ursano, P11 (S100A10) as a potential biomarker of psychiatric patients at risk of suicide. J Psychiatr Res, 2011. 45(4): p. 435-41.
  6. Chen, P.S., T.L. Yeh, I.H. Lee, C.B. Lin, H.C. Tsai, K.C. Chen, N.T. Chiu, W.J. Yao, Y.K. Yang, and Y.H. Chou, Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers–a SPECT study. Neuroimage, 2011. 56(3): p. 1526-30.
  7. Lee, C.Y. and Y.H. Chou, Aripiprazole in treating a manic episode associated with hydrocephalus: a case report. Prim Care Companion CNS Disord, 2011. 13(1).
  8. Su, K.H., J.S. Chen, J.S. Lee, C.M. Hu, C.W. Chang, Y.H. Chou, R.S. Liu, and J.C. Chen, Image segmentation and activity estimation for microPET 11C-raclopride images using an expectation-maximum algorithm with a mixture of Poisson distributions. Comput Med Imaging Graph, 2011. 35(5): p. 417-26.
  9. Tsai, C.W., D. Gunnell, Y.H. Chou, C.J. Kuo, M.B. Lee, and Y.Y. Chen, Why do people choose charcoal burning as a method of suicide? An interview based study of survivors in Taiwan. J Affect Disord, 2011. 131(1-3): p. 402-7.
  10. Yeh, C.B., Y.H. Chou, C.Y. Cheng, M.S. Lee, J.J. Wang, C.H. Lee, C.Y. Shiue, T.P. Su, and W.S. Huang, Reproducibility of brain dopamine transporter binding with Tc-99m TRODAT-1 SPECT in healthy young men. Psychiatry Res, 2012. 201(3): p. 222-5.
  11. Chou, Y.H., S.J. Wang, J.F. Lirng, C.L. Lin, K.C. Yang, C.K. Chen, C.B. Yeh, and M.H. Liao, Impaired cognition in bipolar I disorder: the roles of the serotonin transporter and brain-derived neurotrophic factor. J Affect Disord, 2012. 143(1-3): p. 131-7.
  12. Feng, C.Y., H. Chu, C.H. Chen, Y.S. Chang, T.H. Chen, Y.H. Chou, Y.C. Chang, and K.R. Chou, The effect of cognitive behavioral group therapy for depression: a meta-analysis 2000-2010. Worldviews Evid Based Nurs, 2012. 9(1): p. 2-17.
  13. Liang, C.S., Y.M. Bai, Y.J. Liou, and Y.H. Chou, Acute renal failure after paliperidone overdose: a case report. J Clin Psychopharmacol, 2012. 32(1): p. 128.
  14. Lo, Y.C., Y.H. Chou, and H.Y. Yu, PET finding in Kleine-Levin syndrome. Sleep Med, 2012. 13(6): p. 771-2.
  15. Chou, Y.H., C.K. Chen, S.J. Wang, S.J. Tsai, J.F. Lirng, Y.J. Liou, C.L. Lin, K.C. Yang, M.W. Lin, W.C. Lo, M.H. Liao, and C.C. Chen, Association of brain serotonin transporter availability and brain-derived neurotrophic factor in models of serotonin transporter genotypes in healthy subjects. J Clin Psychopharmacol, 2013. 33(3): p. 432-5.
  16. Chou, Y.H., B.H. Yang, J.W. Hsu, S.J. Wang, C.L. Lin, K.L. Huang, A. Chien Chang, and S.M. Lee, Effects of video game playing on cerebral blood flow in young adults: a SPECT study. Psychiatry Res, 2013. 212(1): p. 65-72.
  17. Chou, Y.H., C.L. Lin, S.J. Wang, J.F. Lirng, K.C. Yang, A. Chien Chang, and M.H. Liao, Aggression in bipolar II disorder and its relation to the serotonin transporter. J Affect Disord, 2013. 147(1-3): p. 59-63.
  18. Chou, Y.H., N.M. Chiu, T.T. Yang, J. Feng, C.C. Chan, and H.K. Lee, An early improvement in depressive symptoms predicts symptomatic remission of schizophrenia treated with quetiapine: a multicenter, 4-week case-control study. Int Clin Psychopharmacol, 2013. 28(5): p. 255-60.
  19. Hsu, J.W., J.F. Lirng, S.J. Wang, C.L. Lin, K.C. Yang, M.H. Liao, and Y.H. Chou, Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study. Bipolar Disord, 2014. 16(3): p. 241-8.
  20. Chou, Y.C., F.H. Chao, and Y.H. Chou, Rapid development of severe skin rash after adding valproic acid in a case of bipolar depression treated with low-dose lamotrigine. J Formos Med Assoc, 2014. 113(3): p. 195-6.
  21. Yang, K.C., S.J. Wang, W.C. Hsieh, J.F. Lirng, C.C. Yang, J.F. Deng, C.L. Lin, and Y.H. Chou, Longitudinal changes in the dopamine transporter and cognition in suicide attempters with charcoal burning. Psychiatry Res, 2015. 231(2): p. 160-7.
  22. Schaffer, A., E.T. Isometsa, L. Tondo, D.H. Moreno, M. Sinyor, L.V. Kessing, G. Turecki, A. Weizman, J.M. Azorin, K. Ha, C. Reis, F. Cassidy, T. Goldstein, Z. Rihmer, A. Beautrais, Y.H. Chou, N. Diazgranados, A.J. Levitt, C.A. Zarate, Jr., and L. Yatham, Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust N Z J Psychiatry, 2015. 49(9): p. 785-802.
  23. Schaffer, A., E.T. Isometsa, J.M. Azorin, F. Cassidy, T. Goldstein, Z. Rihmer, M. Sinyor, L. Tondo, D.H. Moreno, G. Turecki, C. Reis, L.V. Kessing, K. Ha, A. Weizman, A. Beautrais, Y.H. Chou, N. Diazgranados, A.J. Levitt, C.A. Zarate, Jr., and L. Yatham, A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust N Z J Psychiatry, 2015. 49(11): p. 1006-20.
  24. Schaffer, A., E.T. Isometsa, L. Tondo, H.M. D, G. Turecki, C. Reis, F. Cassidy, M. Sinyor, J.M. Azorin, L.V. Kessing, K. Ha, T. Goldstein, A. Weizman, A. Beautrais, Y.H. Chou, N. Diazgranados, A.J. Levitt, C.A. Zarate, Jr., Z. Rihmer, and L.N. Yatham, International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord, 2015. 17(1): p. 1-16.
  25. Wei, H.T., M.H. Chen, W.W. Wong, Y.H. Chou, Y.J. Liou, T.P. Su, T.J. Chen, and Y.M. Bai, Benzodiazepines and Z-drug use among HIV-infected patients in Taiwan: a 13-year nationwide cohort study. Biomed Res Int, 2015. 2015: p. 465726.
  26. Chou, Y.H., P.C. Chu, S.W. Wu, J.C. Lee, Y.H. Lee, I.W. Sun, C.L. Chang, C.L. Huang, I.C. Liu, C.F. Tsai, and Y.C. Yen, A Systemic Review and Experts’ Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder. Clin Psychopharmacol Neurosci, 2015. 13(2): p. 121-8.

2016-2020

  1. Chou, Y.H., J.F. Lirng, W.C. Hsieh, Y.C. Chiu, Y.A. Tu, and S.J. Wang, Neither cortisol nor brain-derived neurotrophic factor is associated with serotonin transporter in bipolar disorder. Eur Neuropsychopharmacol, 2016. 26(2): p. 280-287.
  2. Chou, Y.H., W.C. Hsieh, L.C. Chen, J.F. Lirng, and S.J. Wang, Association between the serotonin transporter and cytokines: Implications for the pathophysiology of bipolar disorder. J Affect Disord, 2016. 191: p. 29-35.
  3. Chang, C.F., R.J. Yang, S.F. Chang, Y.H. Chou, and E.W. Huang, The Effects of Quality of Life and Ability to Perform Activities of Daily Living on Mild Cognitive Impairment in Older People Living in Publicly Managed Congregate Housing. J Nurs Res, 2017. 25(3): p. 187-197.
  4. Wu, C.H., B.H. Yang, Y.H. Chou, S.J. Wang, and J.C. Chen, Effects of 99mTc-TRODAT-1 drug template on image quantitative analysis. PLoS One, 2018. 13(3): p. e0194503.
  5. Lin, M.S., C.C. Lin, C.C. Yang, S.C. Weng, S.M. Wang, C.Y. Chen, N. Huang, and Y.H. Chou, Myocardial injury was associated with neurological sequelae of acute carbon monoxide poisoning in Taiwan. J Chin Med Assoc, 2018. 81(8): p. 682-690.
  6. Higuchi, T., M. Iyo, J.S. Kwon, Y.H. Chou, H.K. Chen, J.Y. Chen, T.T. Chen, S.Y. Huang, J.S. Lee, Y. Saeki, H. Tanaka, T.S. Wang, B.J. Wu, T. Katoh, and J. Ishigouoka, Randomized, double-blind, placebo, and risperidone-controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6-week trial. Asia Pac Psychiatry, 2019. 11(3): p. e12354.
  7. Shih, Y.-C., C.-C. Chou, Y.-J. Lu, Y.-H. Chou, and H.-Y. Yu, Reliability and validity of the Taiwanese version of the Neurological Disorders Depression Inventory for Epilepsy (Tw-NDDI-E). Seizure, 2020. 81: p. 53-57.

2021-

  1. Liu, M.-N., J.G. Pantouw, K.-C. Yang, L.-Y. Hu, Y.-J. Liou, J.-F. Lirng, and Y.-H. Chou, Sub-regional hippocampal volumes in first-episode drug-naïve major depression disorder. Neuroscience Letters, 2021. 763: p. 136178.
  2. Chiu, Y.-C., B.-H. Yang, K.-C. Yang, M.-N. Liu, L.-Y. Hu, Y.-J. Liou, L.-Y. Chan, and Y.-H. Chou, A study of tryptophan, kynurenine and serotonin transporter in first-episode drug-naïve major depressive disorder. Psychiatry Research: Neuroimaging, 2021. 312: p. 111296.
  3. Yang, K.-C., B.-H. Yang, J.-F. Lirng, M.-N. Liu, L.-Y. Hu, Y.-J. Liou, L.-A. Chan, and Y.-H. Chou, Interaction of dopamine transporter and metabolite ratios underpinning the cognitive dysfunction in patients with carbon monoxide poisoning: A combined SPECT and MRS study. Neurotoxicology, 2021. 82: p. 26-34.
  4. Yang, K.-C., M.-N. Liu, Y.-J. Liou, L.-Y. Hu, B.-H. Yang, and Y.-H. Chou, Interleukin-1 family and serotonin transporter in first-episode, drug-naive major depressive disorder: A pilot study. Journal of Psychiatric Research, 2021. 135: p. 174-180.
  5. Yang, K.-C., W.-C. Hsieh, and Y.-H. Chou, Cognitive factor structure and measurement invariance between healthy controls and patients with major depressive disorder. Journal of Psychiatric Research, 2022.
  6. Yang, K.-C.,Chen, Y. Y., Liu, M. N., Yang, B. H., and Y.-H. Chou,  Interactions between dopamine transporter and N-methyl-d-aspartate receptor-related aminoacids on cognitive impairments in schizophrenia. Schizophrenia research, 20222;48, 263–270.
  7. Yang, K.-C.,M.-N. Liu, B.-H. Yang, Chou YH. Role of Dopamine Transporter in the Relationship Between Plasma Cortisol and Cognition. Psychosom Med. 2022;84(6):685-694. 
  8. Liu, M. N., Hu, L. Y., Tsai, C. F., Hong, C. J., Chou, Y. H., Chang, C. C., … & Lau, C. I. Abnormalities of Hippocampal Subfield and Amygdalar Nuclei Volumes and Clinical Correlates in Behavioral Variant Frontotemporal Dementia with Obsessive–Compulsive Behavior—A Pilot Study. Brain Sciences, 2023, 13.11: 1582
  9. Yang, K. C., & Chou, Y. H. Molecular imaging findings for treatment resistant depression. Progress in Brain Research, 2023, 278: 79-116.
  10. Chen CW, Chou YH, Liou YJ, Yang KC, Hu LY, Hsieh WC, Liu MN. Amygdala substructure volumes and serotonin transporter in first-episode, drug- naïve major depressive disorder: A pilot study. J Psychiatr Res. 2023 Apr;160:210-216.